PENTOKEY ORGANY (INDIA) LTD.

Pentokey Organy India Ltd has filed its Annual Report for the financial year ended March 31, 2026, along with the Notice for its 39th Annual General Meeting (AGM). The AGM is scheduled for September 26, 2026, at 3:00 PM and will be conducted via Video Conferencing (VC)/Other Audio Visual Means (OAVM). This filing complies with SEBI and MCA circulars regarding the electronic dissemination of these documents to shareholders. The report includes the audited financial statements, Board's Report, Auditors' Report, and Management Discussion and Analysis.

Pentokey Organy India Ltd has announced that its Board of Directors, in a meeting held on August 13, 2026, has fixed September 26, 2026, as the date for the company's 39th Annual General Meeting (AGM). The AGM will commence at 3 p.m. and will be conducted via video conference or other audio-visual means, in compliance with relevant circulars from the Ministry of Corporate Affairs and SEBI. This meeting pertains to the financial year ended March 31, 2026.

Pentokey Organy India Ltd announced the appointment of Ms. Kavita Kailash Bohra as an Additional Director in the category of Non-executive Independent Director. The appointment is effective from August 13, 2026, for a term of 5 years, subject to shareholder approval. Ms. Bohra is a Chartered Accountant with over eight years of experience in audit, assurance, corporate governance, and regulatory compliance. She is not related to any existing directors and has been recommended by the Nomination & Remuneration committee. This appointment aligns with SEBI regulations for independent women directors.

Pentokey Organy India Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The company reported a total income of ₹20.32 Lakhs and total expenses of ₹229.48 Lakhs, resulting in a profit before tax of ₹24.55 Lakhs. Total comprehensive income for the period stood at ₹39.19 Lakhs. The company's paid-up equity share capital remained stable at ₹627.26 Lakhs, with reserves (excluding revaluation reserves) at ₹318.46 Lakhs. Earnings per share (basic and diluted) were reported at ₹0.35 for the quarter. The results pertain to the Pharma/Pesticides segment and have been prepared in accordance with Ind AS.

Pentokey Organy India Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the results during a meeting held today. The company also submitted a limited review report from its statutory auditors. The financial results pertain to the trading in the Pharma/Pesticides Segment and are prepared in accordance with Ind AS.

Pentokey Organy India Ltd has announced that its Board of Directors meeting is scheduled for August 13, 2026. The primary agenda item is to consider and approve the unaudited financial results for the quarter ended June 30, 2026. Following the announcement of these results, the trading window for the company's securities will reopen 48 hours after the financial results become generally available. The company has also indicated that this intimation is being uploaded to their website.

Pentokey Organy India Ltd has announced the closure of its trading window for dealing in securities. The window will be shut from July 1, 2026, and will reopen 48 hours after the company's unaudited financial results for the quarter ended June 30, 2026, are made public. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. All directors and designated persons have been informed not to trade during this period to prevent potential insider trading.

Pentokey Organy India Ltd has released its audited standalone financial results for the quarter and financial year ended March 31, 2026. The results, approved by the Board of Directors, include an unmodified audit opinion from M/s Verma Mehta & Associates. The company's revenue from operations for the year ended March 31, 2026, was ₹209.00 Lakh. The results pertain to trading in the Pharma/Pesticides segment.

Pentokey Organy India Ltd's Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026. The statutory auditors, Verma Mehta & Associates, issued an unmodified opinion on the financial statements. The meeting commenced at 5:00 PM and concluded at 6:00 PM.

Pentokey Organy India Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The trading window, currently closed as per insider trading regulations, will reopen 48 hours after the financial results are made public. The information has been uploaded to the company's website.